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GENERAL INTRODUCTION 
ovine pneumonia is one of the most common infectious 
diseases of sheep regardless of whether the animals are raised 
intensively indoors or under nomadic conditions (42). The 
disease, characterized clinically by signs of fever, 
depression, nasal discharge, paroxysmal coughing and variable 
mortality, probably ranks as the number one disease affecting 
the world's sheep population. The obvious economic impact of 
this disease results from deaths, reduced growth rate, delayed 
marketing and cost of treatment. An indication of the 
importance of pneumonia in sheep in North America is provided 
by the results of a study by Elazhary et al. (49) which showed 
that nearly 30% of sheep and goats in Quebec, Canada suffered 
from respiratory disease. A more recent survey conducted in 
Michigan, USA by Rook (125) found that 17% of pre-weaning 
mortality of lambs was due to pneumonia. In Africa, studies 
conducted in Sudan (1) and in Mali (103) indicated that 
respiratory diseases were common problems in sheep and goats. 
In Iowa, economic losses to sheep producers from respiratory 
diseases are also significant. A survey of Iowa sheep 
producers conducted by Hartwig and Eness (67) indicated that 
pneumonia was one of their most important disease problems. 
Pneumonia in sheep is caused by the complex interaction 
of environmental factors producing stress and a variety of 
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microorganisms acting synergistically (42,143). Among these 
microorganisms, Pasteurella fil2· are considered the most 
commonly isolated from both pneumonic and normal sheep. 
However, challenge experiments have shown that Pasteurella fil2· 
alone have limite d ability to produce pneumonia and probably 
require a predisposing infection by another infectious agent 
(42,86,143). A number of microorganisms, including viruses, 
mycoplasmas and chlamydia have been suggested to play this 
role. 
Mycoplasma ovi pneumoniae has been isolated from the lungs 
of pneumonic as well as normal sheep in many countries 
(5,6,15, 42,96,111). During outbreaks of respiratory disease 
in Iowa sheep, a serological response to M· ovipneurnoniae and 
£. hemolytica was demonstrated (90,50). These results provided 
evidence for the involvement of M· ovipneumoniae and £. 
hernolytica in the disease process. At the same time, no 
significant antibody titers for parainfluenz a-type 3 (PI3), 
infectious bovine rhinotracheitis (IBR) respiratory syncytial 
(RS), or bovine viral diarrhea (BVD) viruses were noted. 
Mycoplasmas possess various virulence factors including 
suppression of the host pulmonary defence mechanisms that may 
facilitate colonization of the respiratory tract by secondary 
infectious agents. Many in vitro studies have shown that in 
the absence of specific antibodies rnycoplasrnas not only can 
survive in c ulture with phagocyti c cells but also interfere 
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with ingestion and killing of a second bacterial target 
(11,75,115,137,149). Theoretically, mycoplasma-mediated 
alterations in phagocytic cell function could have major 
adverse effects on disease processes in the respiratory tract. 
However, as far as M· ovipneumoniae is concerned little is 
known of its inter-relationship with the defense mechanisms of 
ovine lung (3). In the following study, the ability of M· 
ovipneumoniae (field strain) to alter sheep alveolar 
macrophage functions was examined in vitro. In addition, 
attempts were made to determine surface receptors for Fe 
component of globulin and complement on sheep alveolar 
macrophages and the effect of M· ovipneumoniae on their 
expression. 
Explanation of Thesis Format 
This thesis consists of a general introduction, review of 
the literature, one paper suitable for publication (composed 
of an abstract followed by introduction, materials and 
methods, results, discussion and references sections), general 
summary and conclusions, literature cited in the general 
.introduction, literature review, and summary and conclusions, 
and acknowledgments. 
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LITERATURE REVIEW 
Many of the respiratory diseases associated with 
mycoplasmas are complex and may have a multifactorial 
etiology. While the etiologic role of mycoplasmas has clearly 
been demonstrated with certain mycoplasmal organisms in 
specific hosts, their role in other instances has not been 
confirmed. Isolation of mycoplasmas from apparently healthy 
animals is not an unusual occurrence. Even though extensive 
experimentation has been reported on the mechanisms of 
pathogenesis of mycoplasmas, it is clear that the subject is 
extremely complex and there is a need for additional 
information . Establishment of cause and effect or fulfillment 
of Koch's postulates has been difficult. The virulence factors 
of mycoplasmas can be divided into four main functional 
components: (1) adherence to host tissues, (2) toxin 
production, (3) nonspecific activation of host immune 
responses, and (A) suppression of the host defence mechanisms 
leading to secondary bacterial infection. This last component 
may be an important mechanism by which mycoplasmas can 
contribute to respiratory diseases in humans and animals. 
Immunosuppression has been studied with .several respiratory 
mycoplasmas but , little information is available on M· 
ovipneumoniae. Therefore, this literature review will address 
interactions of mycoplasmas i n general wi th host immune system 
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cells. Prior to that, a brief review of the etiology of 
respiratory disease of sheep is presented. A review of surface 
receptors on phagocytic cells is also included. 
Etiology ot Sheep Pneumonia 
Ovine pneumonia is a very common infectious disease of 
sheep worldwide regardless of the management system (42). 
Points which emerge from the literature are the confusion in 
the terminology and the classification of pneumonias of sheep 
since, in the past, this has been based primarily upon the 
morphology of the lesions. Traditionally, most pneumonias of 
sheep have been classified as either an acute exudative type 
resembling acute pneumonic pasteurellosis or a chronic 
proliferative type resembling atypical pneumonia (42). 
The etiology of sheep pneumonia is very complex and has 
not been clearly defined. The available information has been 
derived from isolation of microorganisms from pneumonic lungs 
and attempts to reproduce the disease with an individual agent 
or a combination of agents. Establishment of cause and effect 
or fulfillment of Koch's postulates has been difficult due to 
the complex etiology and the poorly defined lesions. 
A wide variety of microorganisms have been isolated from 
the respiratory tract of pneumonic sheep including Pasteurella 
§12., Mycoplasma §12., chlamydia, viruses , nematode parasites, 
fungal agents, and occasionally other bacteria such as 
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Escherichia coli, Corynebacterium §R., Staphylococcus §R., 
Neisseria §R. (7,8,42,143), and nonidentified Gram negative 
bacteria (21). Among these microorganisms, Pasteurella §R· are 
reported to be the most commonly isolated from both pneumonic 
and normal sheep . It is often found in pure culture in lungs 
with acute exudative pneumonia but also may be present in 
cases of chronic proliferative pneumonia. However, in all 
these lesions, it is not unusual to find Pasteurella §R. in 
association with Mycoplasma §R. and many other bacteria . 
There have been many attempts to reproduce ovine 
pneumonia with a single agent or combinations of 
microorganisms. A number of viral agents including PI3, 
several types of adenoviruses and reoviruses were reported to 
induce clinical disease which was usually self limiting 
(42,143). The majority of lambs inoculated with Chlamydia 
psittaci developed pneumonia with lesions resembling atypical 
pneumonia but the infection did not persist (42). Attempts to 
induce ovine pneumonia with pure cultures of Pasteurella 
hemolytica have given inconsistent results. In most cases, the 
bacteria were rapidly cleared from the respiratory tract 
although sometimes they persisted and multiplied to induce 
exudative pneumonia or, occasionally, a proliferative type of 
lesions (86). 
Historically, the isolation of Mycoplasma §R. from the 
respiratory tract of sheep was first reported in 1955 by Greig 
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(64). However, a potential role for mycoplasmas in ovine 
pneumonia was initially suggested by Hamdy et al. (65) who 
consistently were able to reproduce the disease by stressing 
lambs inoculated intratracheally with a mycoplasma agent and 
Pasteurella multocida. Meanwhile, there were reports of 
isolation of mycoplasma from the respiratory tract of 
pneumonic sheep in many countries (88). Also, some 
investigations conducted in Australia associated Mycoplasma 
.§12. with many cases of pneumonia appearing in lambs 5 to 10 
weeks of age (142,145). Clinical signs reported were coughing, 
sneezing and a mucoid nasal discharge. While the morbidity was 
high the mortality was low. The lungs from all animals that 
died or were sacrificed had pneumonic lesions that were 
characterized as a proliferative interstial pneumonia. At the 
same time, a cytopathogenic agent was cultivated in bovine 
testicular cell culture and pneumonia similar to the natural 
disease was produced in lambs by intratracheal inoculation of 
the cell culture grown organisms. Further studies by 
Carmichael et al. (24) confirmed the nature of the agent and 
it was named M· ovipneumoniae . 
Surveys conducted in many countries have shown that M· 
ovipneumoniae is the most commonly isolated mycoplasma from 
ovine lungs (15,111) as well as from the ovine nasal cavity 
(23). The agent is also commonly isolated from proliferative 
types of pneumonia as well as from lungs with typical 
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exudative pneumonia, from chronic pneumonias that followed a 
viral infection, and from normal lungs (42). Other Mycoplasma 
fil2· including M· arginini, Acholeplasma laidlawii and 
ureaplasmas have also been recovered from the respiratory 
tract of both pneumonic and normal sheep (23,42). However, 
like M· ovipneumoniae, their role in the causation of the 
disease is not well proven. 
Attempts to produce pneumonia in sheep with pure cultures 
of M· ovipneumoniae have yielded variable results. In some 
early studies conducted in Australia, nearly all animals 
developed severe pneumonia (142,145). On the other hand, only 
25 to 50% of the animals developed mild pneumonia in studies 
conducted in Scotland (53,61), and less than 20% showed 
lesions in experiments conducted in New Zealand (5,43). 
Attempts to recover M· ovipneumoniae from the pneumonic lungs 
in all these experiments usually were unsuccessful and, even 
where M· ovipneumoniae was present, bacterial numbers in both 
healthy and pneumonic lungs were similar . Because of the 
inconsistent results in producing the experimental disease and 
the failure to recover the agent from the lesions, the results 
of these experiments did not establish the etiological 
significance of M· ovipneumoniae beyond doubt. However, 
attempts to produce the disease in lambs with a homogenate of 
pneumonic lung containing M· ovipneumoniae alone or in 
combination with £. hemolytica have yielded proliferative 
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pneumonia in most animals (86). This has led to the hypothesis 
that the challenge organisms in the early studies might have 
been attenuated during isolation and cloning on artificial 
medium or that strains varied in virulence (83,86,87). In this 
regard, it is interesting to note that the early studies were 
conducted utilizing tissue culture grown organisms. Another 
factor of variability in the challenge studies could be the 
nature of the experimental animal. Naturally-reared lambs were 
more likely to develop pneumonia than were specific pathogen-
free animals (86). 
Host Phaqocytic Cell Defence Mechanisms 
The major phagocytic cells of mammals belong to two 
complementary systems. The mononuclear-phagocyte system, 
consists of circulating monocytes and tissue macrophages. The 
second is represented by the polymorphonuclear neutrophil 
granulocytes also known as neutrophils . Their major function 
is the destruction of invading microorganisms through the 
process of phagocytosis. A successful phagocytic action by 
phagocytic cells requires directed migration of phagocytes, 
attachment, ingestion, phagosome-lysosome fusion, stimulation 
of oxygen-independent and oxygen-dependent killing mechanisms, 
and activation of spec i fi c immune responses and cytokine 
production (41,59,95). 
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Phagocytic cells are attracted by many bacterial products 
such as N-formylated tripeptides, by factors released by 
damaged cells, or by activation of components of the 
complement system such as C5a and C3a (41}. 
Once the phagocytic cells encounter the invading 
microorganism, they must bind it firmly. This attachment is 
usually mediated through antibody molecules and the third 
component of complement (C3), known as opsonins. Neutrophils 
and macrophages carry specific receptors for the Fe portion of 
antibody molecules and C3 on their surface (59}. Therefore, 
particles coated with these molecules facilitate their binding 
to the phagocytic cells. After attachment is complete, the 
phagocytes will attempt to internalize the particles into a 
vacuole called a phagosome. Antibodies and C3 again play a 
major role in this process by rendering the surface of the 
particles more hydrophobic. However, it is reported that 
receptors for C3 promote only binding but not ingestion of 
some particles (18,66,94}. 
Destruction of the ingested particles occurs mainly 
through two distinct mechanisms, oxygen-independent and 
oxygen-dependent. Within the cytoplasm of phagocytic cells are 
several granules (lysosomes} that contain microbicidal enzymes 
such as lysozyme, proteases and peroxidase . Fusion of 
phagosome to these lysosomes (phagolysosornes} triggers the 
release of the lysosornal enzymes that can kill most 
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microorganisms. Of more importance in destroying infectious 
agents is the oxygen-dependent mechanism known as the 
respiratory burst. Changes in the plasma membrane initiate an 
intracellular activation of cytochrome oxidase that result in 
a burst of oxygen consumption. This leads to the production of 
highly toxic oxygen metabolites such as superoxide anion, 
hydrogen peroxide, hydroxyl radicals and singlet oxygen 
(41,59). In most instances, the infectious agents are killed 
by this oxidative burst. However, in some cases, the organisms 
escape and the animal must initiate an appropriate immune 
response to augment its defence mechanisms. Even more, 
elimination of some intracellular pathogens requires induction 
of specific T cell products known as lymphokines that activate 
phagocytic cells and other T cells to kill these pathogens 
( 39) . 
Another mechanism by which phagocytic cells contribute to 
host defence against infectious agents is their ability to 
lyse these infectious agents through a process termed 
antibody-dependent cellular cytotoxicity (ADCC) or complement-
dependent cellular cytotoxicity. Cells that possess receptors 
for the Fe region of immunoglobulins and C3b may bind to 
foreign target cells in the presence of specific antibody and 
complement. Cells that can participate in this process include 
macrophages, neutrophils, eosinophils, killer (K) cells, and 
some subsets of T-lymphocytes (68,135). The mechanism of this 
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cytotoxicity is unknown, although, the concept of a granule 
exocytosis model as proposed by Henkart (68) is generally 
accepted at least for cytotoxic T cells and K cells. According 
to this concept, cytoplasmic granules fuse with the plasma 
membrane of the target cells and at the cytotoxic cell-target 
cell interface a number of substances including a potent 
cytotoxic pore-forming material known as perforin are 
released. 
Despite these antimicrobial defences of the host, some 
pathogenic organisms have developed methods to circumvent the 
killing process of phagocytic cells, and in some cases they 
used host defence cells for their own advantage. The common 
strategy utilized by many pathogenic organisms to avoid 
destruction by host cells is to circumvent one or more of the 
events outlined above. 
Bacteria-Phaqocytic Cell Interactions 
Some pathogenic organisms including mycoplasma species 
and gonococci readily attach to phagocytic cells without being 
ingested and proliferate on the surface of these cells. This 
may compromise the ability of these phagocytes to ingest and 
kill a second bacterial agent. However, addition of specific 
antibodies against these agents promotes ingestion and killing 
by the phagocytic cells (41). 
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Another very effective mechanism used by pathogenic 
microorganisms to minimize their interaction with the 
phagocytic cells is to inhibit phagosome-lysosome fusion. 
Legionella pneumophila, a facultative intracellular Gram-
negative bacterium which causes Legionnaires' disease, is 
capable of multiplying in human alveolar macrophages by 
inhibiting phagosome-lysosome fusion, thus evading the killing 
mechanism of macrophages (41,71) . Inhibition of phagosome-
lysosome fusion also has been documented for Brucella abortus, 
mycobacterium species and chlamydia (41). 
Pathogenic microorganisms also have developed various 
tactics to avoid the oxidative killing mechanism of phagocytic 
cells. Haemophilus somnus has been shown to limit the 
respiratory burst of bovine neutrophils as measured by the 
iodination test, and a low molecular weight nucleotide has 
been incriminated (29,79). Similarly, Toxoplasma gondii has 
been shown to fail to induce the release of the macrophage's 
reactive oxygen metabolites (27). Failure of other bacteria 
including ~. abortus and Salmonella typhi to stimulate an 
oxidative burst when they are ingested also has been reported 
(41). Other bacteria such as Listeria monocytogenes produce a 
large amount of superoxide dismutase that converts oxygen 
radicals to hydrogen peroxide which can be inactivated by 
catalase enzyme (41). 
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An avoidance mechanism of certain microorganisms is 
through the production of specific cytotoxins. Respiratory 
bacterial pathogens including £. haemolytica and fi. somnus 
produce cytotoxins, known as leukotoxin that are highly toxic 
for alveolar macrophages (40). In the same way, H· 
pleuropneumoniae extracts were cytocidal for swine alveolar 
macrophages (112) . 
In addition, the production of antiphagocytic surface 
components such as capsules help some pathogenic 
microorganisms to avoid phagocytosis. For instance, £. 
haemolytica avoids phagocytosis by means of its capsular 
material that can adversely affect bovine neutrophil 
phagocytic function (40). Numerous other examples include ~. 
aureus, Corynebacterium egui, and Klebsiella pneumoniae (41). 
The mechanisms by which the capsular material protects 
bacteria from phagocytosis include decreased binding of serum 
opsonins, inaccessibility of ligands, and decreased 
hydrophobicity of the bacterial surface (41). 
surf ace Receptors on Phaqocytic Cells 
Phagocytic activity of phagocytic cells depends heavily 
on their membrane receptors including Fe and complement (C) 
receptors which mediate both particle attachment and 
endocytosis. The importanc e of these surface receptors in 
host defence mechanisms relies also on their ability to 
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mediate cytotoxicity through antibody-dependent cellular 
cytotoxicity or complement-dependent cytotoxicity. Even though 
the expression of these surf ace markers appears to correlate 
with cell differentiation, a variable number of mature cells 
can usually be demonstrated to not express either class of 
receptor markers (117). In addition to macrophages and 
neutrophils, basophils, eosinophils and subsets of lymphocytes 
are also reported to possess similar surface receptors. 
Studies on Fe receptors (FcR) have shown that all 
immunoglobulin (Ig) classes are capable of binding to immune 
cells, although some cells are found to have more affinity for 
certain Ig classes than others (63,138,141,144,156). It seems 
likely that IgG molecules bind to macrophages and neutrophils 
with high avidity, while IgE molecules bind more to 
eosinophils and basophils. However, due to the complexity of 
the subject, only the main points concerning FcR for IgG will 
be cited here. 
Heterogeneity and binding specificity of FcR for IgG on 
murine macrophages are probably the best studied, and at least 
two different types of FcR for IgG have been identified 
(151,123). This heterogeneity of Ig FcR was first observed by 
Kossard and Nelson (97) who demonstrated that erythrocytes 
sensitized with early antisera failed to form rosettes with 
trypsinized macrophages, whereas erythrocytes sensitized with 
hyperimmune serum formed rosettes with both trypsinized and 
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nontrypsinized macrophages. This suggested the presence of 
more than one class of receptor for IgG molecules on murine 
macrophages. Furthermore, studies conducted by Askenase and 
Hayden (14), Unkeless and Eisen (152), Reusser et al. (69), 
and Diamond et al. (46) provided evidence that the IgG 
subclass that bound to a trypsin-sensitive ~ite was IgG2a. 
Although the presence of more than one class of receptors for 
IgG on mouse macrophages is recognized by almost all these 
investigators, their exact number still remains unclear . 
Binding and competitive inhibition studies have yielded 
conflicting results. Walker (158) used normal macrophages and 
macrophage cell lines to demonstrate that binding of monomeric 
or aggregated IgG2a was not inhibited by aggregated IgG2b, 
suggesting the existence of two binding sites. Diamond et al. 
(46), using two different macrophage cell lines as well as 
normal macrophages, also found some evidence for two binding 
sites, one for IgG2a and other for IgG2b. In contrast, Heusser 
et al. (69) and Anderson et al. (12) found three binding sites 
on mouse macrophages as well as macrophage cell lines. 
The human FcR, as in the mouse, are also heterogenous and 
show different affinities for IgG subclasses. Three distinct 
types of FcR have been determined . FcRI binds to monomeric IgG 
with high affinity and in rank order of affinity to 
IgGl=IgG3 >IgG4. It is expressed mainly on macrophages. The two 
other receptors termed FcRII and FcRIII have lower affinity 
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for IgG. FcRII binds to all subclasses of IgG and is expressed 
on phagocytic cells, B cells and platelets. On the other hand, 
FcRIII preferentially binds to IgGl and IgG3, and is expressed 
on all types of phagocytes and lymphocytes (95,153) 
In contrast to murine species and man, the domestic 
animal IgG subclass specificity for FcR has not been well 
documented. Reports in the literature have been confined 
mainly to evaluations of the presence of receptors for IgG 
complexes. Therefore, the existence of functionally and 
antigenically distinct FcR for IgG among domestic animals 
leukocytes remains to be further investigated. However, 
studies of FcR for IgG isotypes on bovine phagocytic cells by 
the rosette formation technique have shown that neutrophils 
produced more rosettes with IgG2-coated erythrocytes than with 
IgGl-sensitized cells . When bovine macrophages were examined 
by the same method, it was found that receptors for IgGl were 
more frequent than those for IgG2 (77). Other studies showed 
no difference in numbers of IgGl and IgG2 receptors on bovine 
monocytes (132) . Howard (74) compared the ability of bovine 
IgGl and IgG2 to promote killing of M· bovis by bovine 
alveolar macrophages and neutrophils and found that both IgGl 
and IgG2 promote mycoplasma killing by macrophages, while only 
IgG2 promote d kill i ng by neutrophils. These results provided 
some evidence for the existence of different types of 
receptors for IgG subclasses on bovine phagocytes. Similarly, 
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binding of subclasses of sheep IgG on sheep phagocytes was 
examined by Fleit et al. (52) using an immunofluorescence 
technique. It was found that alveolar macrophages bound IgGl 
but not IgG2, while peripheral neutrophils bound IgG2 but not 
IgGl. This is similar to the results obtained from cattle. 
However, the existence of different types of FcR for IgG 
subclasses in both bovine and ovine phagocytic cells needs to 
be further investigated. 
In addition to macrophages, other phagocytic cells and B 
lymphocytes also have on their surface a variety of receptors 
specific for the third component of complement (CJ) that are 
detected by red blood cells sensitized with IgM and reacted 
with serum complement. At the present time, at least nine 
different types of complement receptors (CR) are believed to 
exist. However, only four of these have been fully 
characterized. These are designated as: CRl which binds to 
CJb, C4b, iC4b and with much lower affinity to iCJb, CR2 which 
is specific for CJd, CJdg (region of the C3b fragment that 
becomes exposed after cleavage of C3b into iCJb) and iCJb, CRJ 
which binds to iCJb and with much lower affinity to C3dg and 
CJd, and CR4 which is structurally distinct from CR2 but has 
similar ligand specificity (95,130). Macrophages and 
neutrophils have been shown to express CRl, CRJ, and CR4 type 
receptors but not CR2. On the other hand, B lymphocytes have 
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on their surface membrane CRl, CR2, and CR3 type receptors but 
not CR4 (95,131). 
The function of the various CR appears to vary depending 
on the type of cells that carry them. For example, CRl that is 
expressed also on erythrocytes is involved in the clearance 
and neutralization of circulating immune complexes by binding 
and carrying them into the liver and spleen, where they are 
destroyed by macrophages. On the other hand, its function on 
macrophages and neutrophils is to opsonize particles for 
phagocytosis and cytotoxicity (95). 
Although FcR for IgG and C receptors have been described 
on bovine (77,105), caprine (100), swine (28,66), equine (48), 
human (119), guinea pigs (82), and to a limited extent, on 
ovine (52) phagocytic cells, the effects of microorganisms on 
their expression is not well documented. However, Caruso and 
Ross (25) reported that alveolar macrophages from pigs 
experimently infected with M· hyopneumoniae and Actinobacillus 
pleuropneumoniae had greater phagocytic activity towards 
sensitized and nonsensitized sheep red blood cells than 
noninfected control pigs . Similarly, Harmsen and Jeska (66) 
found that infection of pigs with Toxoplasma gondii resulted 
in an increased number of pig AM exhibiting C receptors, while 
the number of FcR for IgG remained unchanged compared with the 
noninfected control pigs. However, they concluded that this 
augmentation of C receptors did not independently enhance the 
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ability of these pig AM to endocytose SRBC. It is interesting 
to note that both studies were performed under in vivo 
conditions. It has also been shown that intraperitoneal 
injection of some substances such as thioglycollate medium or 
bacillus Calmette-Guerin into mice resulted in the activation 
of peritoneal macrophages by increasing their surface 
receptors (18). In contrast, administration of glucocorticoids 
in guinea pigs (110) and human (55) decreased the expression 
of FcR on phagocytic cells. Similarly, prolonged exposure of 
guinea pigs to corticosteroids in vivo can cause alterations 
in membrane Fe receptor function of AM (81) and the loss of 
these Fe receptors caused a marked decrease in cytotoxic 
effector function of these macrophages (80). 
Pathogenesis of Mycoplasmal Infection 
The ability of an infectious agent including mycoplasmas 
to invade and initiate disease is dependent on a complex 
interaction with host defence mechanisms. Mycoplasmas are, in 
general, pathogens of the mucosa! surfaces and therefore 
resistance at this site will determine the outcome of the 
infection. At this level, the role of host phagocytic cells in 
containing the invaders is of major importance. Both 
neutrophils and macrophages are professional phagocytes 
capable of trapping and destroying particulate materials 
through the action of various mechanisms. However, many 
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infectious agents, including Mycoplasma .§R., have evolved 
several virulence factors that allow them to resist and 
colonize the host tissues. 
Virulence Factors 
Adherence to Host Tissues Attachment of mycoplasmas to 
host cells is crucial for their survival within a host. The 
general ability of mycoplasmas to attach to host cells has 
been studied most extensively with the respiratory pathogens, 
in particular M· pneumoniae, the causative agent of atypical 
pneumonia in man. The consequences of attachment of 
mycoplasmas are often injury to the host cell including 
biochemical alterations such as decreases in ATP, cyclic AMP, 
carbohydrate utilization and oxidative metabolism (26). 
Even though hemadsorption of red cells by M· pneumoniae 
was described first by Del Guidice and Parvia (45), early 
information available on the importance of the attachment 
process in the pathogenicity of mycoplasmas came from 
Sobeslavsky et al. (139) who reported the utilization of 
neuraminic acid receptors of host cells by M· pneumoniae. 
Shortly thereafter, Manchee and Taylor-Robinson (104) 
confirmed these findings, denoted differences in the avidity 
for neuraminic acid receptors among strains of M· 
gallisepticum, and concluded the existence of a receptor 
gradient that might reflect differences in pathogenicity. 
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Collier and Baseman (38) suggested that neuraminic acid 
was a component of receptors of host cells since treatment of 
tracheal rings with neuraminidase could partially inhibit 
adherence. They also noted that avirulent mycoplasmas were not 
capable of adhering to the tracheal rings, and suggested that 
a tip-like structure seemed to be necessary for attachment. In 
1976, Powell et al. (114) also demonstrated the ability of 
neuraminidase to impair attachment of M· pneumoniae to 
tracheal rings. Further studies on cell receptors for M· 
pneumoniae confirmed that adherence occurs through the 
interaction of membrane proteins of the microorganisms to a 
receptor moiety on the surface of host cells . The adhesin is 
the Pl protein concentrated in a tip structure of the 
microorganism but also present on other areas of the membrane. 
However, the importance of the Pl in attachment in vivo is not 
completely understood since avirulent strains of M· pneumoniae 
are unable to attach to host cells but still they possess the 
Pl protein (37). 
A considerable number of Mycoplasma ~· other than M· 
pneumoniae have been shown to possess the ability to adhere to 
host cells. M· gallisepticum attaches to the tracheal 
epithelium of chickens by means of its organelles (154), and a 
glycophorin (glycoprotein) was reported to be its specific 
receptor (16). The existence of cross reactions between 
epitopes of Pl protein of M· pneumoniae and a similar size 
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protein in M· gallisepticum was noted (30), although the 
binding protein has not been fully characterized. On the other 
hand, adherence of M. pulmonis to host cells was shown to be a 
different process than that of M· pneumoniae and M· 
gallisepticum. It was shown that neuraminic acid did not act 
as a receptor in host cells and that the organism lacked an 
attachment organelle (108,146). Consequently, it was 
speculated that adhesion of M· pulmonis to host cells was 
mediated by a general interaction of a capsule-like surface 
material on its membrane with the host cells. Cytadsorptive 
virulent strains of M· pulmonis have more capsular material 
than substrains that have been passaged in vitro until they 
are no longer virulent {146). It has also been proposed that 
the capsular material of M· dispar, a causative agent of 
pneumonia in calves and M· hyopneumoniae, the etiologic agent 
of enzootic pneumonia in swine, plays an important role in the 
colonization of respiratory tract through the attachment 
process {128). Recently, Rosenbusch {126) proposed a role for 
superoxide dismutase (SOD) in the mucosal-colonizing 
mycoplasmas since several species of mycoplasma that are 
mucosal colonizers including M· bovoculi, M· bovirhinis, M· 
arginini, M· dispar and M· hyopneumoniae were found to produce 
the enzyme. On the other hand, M· bovis, M· gallisepticum, M. 
pulmonis and M· pneumoniae, which are known to be capable of 
causing systemic infections, were found not to produce SOD. 
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Concerning M· ovipneumoniae, even though experimental 
studies revealed its ability to induce ciliostasis and loss of 
cilia in ovine cells (85), no information on its mechanisms of 
adherence to host cells has been reported. 
Toxin Production The neurotoxicity of M· neurolyticum, 
the causative agent of rolling disease in mice and rats, has 
been recognized since the work of Sabin (133). Neurotoxic 
properties of 3 other species, M· arthritidis, M· pulmonis and 
M· gallisepticum, were described by Thomas (148) who showed 
that the organisms must be alive to produce toxin and larger 
doses must be used to produce toxicity. 
The spiroplasmas from plants can also affect neurologic 
tissue when inoculated into appropriate hosts, although the 
role of toxins has not been clearly demonstrated (57). There 
are reports that the corn stunt spiroplasma can colonize the 
neural tissue of its natural insect vectors resulting in 
behavioral abnormalities such as irritability (57). 
Spiroplasma mirum, a causative agent of suckling mouse 
cataract is also reported to affect ocular and neural tissues 
of rodents (57) . 
Many of the mycoplasmas causing pneumonia induce 
ciliostasis and loss of cilia. It is believed that the basis 
for these cytopathic changes might be due to oxidative attack 
by hydrogen peroxide on host cell membranes. M· pneurnoniae 
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actively produces superoxide anions as well as hydrogen 
peroxide. These can be introduced into the host cell through 
the beneficial effects of intimate contact with the cell 
membrane. Once within the cell, the superoxide anions 
inactivate the host epithelial catalase enzyme, thus 
permitting the oxidative action of hydrogen peroxide produced 
by both the organism and the host cells (9,91). Hydrogen 
peroxide is also reportedly produced by M· hyorhinis (113), 
and Acholeplasma laidlawii (118). However, this role of 
hydrogen peroxide in the pathogenicity of mycoplasmas needs to 
be further investigated since some known highly pathogenic 
mycoplasma species such as M· hyopneumoniae (113) and M· 
hyosynoviae (129) do not produce hydrogen peroxide. Gabridge 
and Barden-Stahl (58) proposed a role of adenine in the 
ciliostasis induced by M· pneumoniae. The transfer of adenine 
from the host cell membranes to the microorganisms decreases 
the quantity of ATP available to the cell and results in loss 
of energy for ciliary motion. 
Other potential mediators of toxicity in mycoplasma 
infections are galactan, a phenol-water extract of M· mycoides 
subsp. mycoides and lipoglycan extracted from several 
Acholeplasma species. The evidence that these two products may 
play a pathologic role similar to the endotoxin of gram 
negative bacteria has been suggested by several authors over 
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the past years, although biochemically they are different from 
classical lipopolysaccharide (LPS} (101,136,155,157). 
The possibility that mycoplasma pathogenicity might be 
linked to certain types of enzymes (proteases, collagenases) 
has also been investigated. Liquefaction of formalin-denatured 
gelatin by cultures of M· mycoides subsp. mycoides and subsp. 
capri was described by Freundt (54). Liquefaction of 
coagulated serum by M· capricolum and M· mycoides subsp . 
mycoides has also been described (57). Proteases specific for 
IgA have been found in Ureaplasma urealyticum (93,122}. 
Several other factors which may play a role in the 
pathogenesis of mycoplasmal disease have been reported. A 
polysaccharide capable of eliciting an inflammatory response 
in the skin of guinea pigs and the mammary gland of cows was 
extracted from the membrane of M· bovis (60). Two membrane 
proteins of M· hyopneumoniae have been shown to be responsible 
for the cytotoxicity for porcine pulmonary fibroblasts (128}. 
Interactions with the Immune system 
Mycoplasma-Pbagocytic Cell Interactions An important 
feature of several species of mycoplasma including those that 
cause r~spiratory infections is their ability to survive quite 
well in cultures of macrophages and neutrophils in the absence 
of specific antibodi es. Thi s phenomenon has been observed wi th 
M· pneumoniae (2 2 ,115), M· pulmonis (89}, M· bovis (78) and M· 
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dispar (11,78). The mechanism by which mycoplasmas inhibit the 
phagocytic capacity of phagocytes is unknown. In addition to 
anti-phagocytic capsular material found in some mycoplasma 
species (11,73), it can be speculated that this survival may 
be due to a passive mechanism. The intimate contact of 
mycoplasmas with the cell membranes of the phagocytes may 
prevent the stimulation of appropriate receptors, or even when 
stimulated, the density is insufficient for engulfment (72). 
Thus, this may also compromise the ability of phagocytic cells 
to ingest and kill a second bacterial target. In this regard, 
M· hominis, M· arthritidis (137,149), M· bovis (75), and M. 
dispar (11,75) have already been reported to interfere with 
the ability of phagocytic cells to phagocytose Escherichia 
coli or Staphylococcus aureus in vitro. However, there are 
reported findings that M· arthritidis did not attach to cells 
but still inhibited phagocytosis (73). Furthermore, Thomsen 
and Heron (149) demonstrated that in vivo exposure of rat 
neutrophils to M· arthritidis and M· hominis also depressed 
their ability to cause phagocytosis of ~- coli. Caruso and 
Ross (25) also reported that the percentage of AM 
phagocytosing opsonized sheep RBC was not affected by in vivo 
infection of pigs with M· hyopneurnoniae alone but, was 
suppressed by a combined infection with M· hyopneumoniae and 
Actinobacillus pleuropneumoniae. 
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In contrast, certain investigators have reported that 
mycoplasmas were found to activate macrophage phagocytic 
activity. Normal mouse peritoneal macrophages in the presence 
of M· arginini or M· pulmonis, enhanced their cytotoxicity for 
target cells and their microbicidal capacities for 
intracellular organisms (70) . This is difficult to reconcile 
with the previously mentioned in vitro and in vivo studies. It 
is interesting to note that certain microorganisms other than 
mycoplasmas have been also observed to interact with normal 
macrophages and neutrophils in vitro, resulting in an impaired 
ability to phagocytose a second bacterial target. Examples 
include Pseudorabies virus (56), Haemophilus somnus (79), and 
Salmonella choleraesuis (124). 
Paradoxically, there are reported findings that 
mycoplasmas were phagocytosed in the absence of specific 
antibodies. Webster et al (159) reported that four different 
mycoplasmas of human origin, M· pneumoniae, M· hominis, M· 
salivarium and Q. urealyticum were engulfed by human 
neutrophils in the absence of specific antibodies. However, 
they concluded that mycoplasmas survived within the 
neutrophils unless they had been opsonized with antibodies 
prior to engulfment. In addition, Davis et al. (44) reported 
that rat alveolar macrophages were able to exert an 
antimycoplasmal effect regardless of the presence or absence 
of specific antibody. In the same way, reports exist of 
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failures of phagocytes to phagocytose mycoplasmas even in the 
presence of specific antibodies (137). This led to the 
speculation that to explain mycoplasma-phagocytic cell 
interactions in vivo it is essential to use mycoplasmas, 
phagocytic cells, and antisera from the natural host (73,75). 
However, even with such homologous systems, there are 
conflicting results. It has been reported that M. arthritidis 
was not phagocytosed by mouse or rat macrophages in the 
presence of mouse or rat convalescent sera, but phagocytic 
action was observed in the presence of rabbit antiserum (36). 
Also, Davis et gl. (44) found that mouse alveolar macrophages 
required hyperimmune rabbit serum but not mouse hyperimmune 
serum to phagocytose M· pulmonis. In contrast, Taylor and 
Howard {147) found that convalescent mouse serum promoted the 
phagocytosis of M· pulmonis by mouse peritoneal macrophages 
and neutrophils. Also, M· bovis and M· dispar were 
phagocytosed by bovine alveolar macrophages and mammary 
neutrophils in the presence of bovine antisera (78). Howard 
and Taylor (73) suggested that the failure of sera to show 
opsonic activity may be related to the isotype response to the 
mycoplasmas or of some other defect of the antibody response 
since studies have shown that IgG2 antibody was more effective 
than IgGl antibody in promoting killing of mycoplasmas by 
peripheral-blood neutrophils (74). 
30 
While extensive study has been reported on the 
experimental infection of sheep with M· ovipneumoniae 
(4,5,43,86,87,88,142,145), current knowledge of its 
interaction with phagocytic cells is extremely limited. 
Electron microscopic studies by Al-Kassi and Alley (3) showed 
that, in the absence of specific antibodies, the organisms 
remained attached to the surface of sheep alveolar macrophages 
without inducing phagocytosis. The addition of specific 
antibodies stimulated phagocytosis. 
The role of cytokines, in particular tumor necrosis 
factor {TNF) and interleukin 1 (IL-1) produced primarily by 
macrophages, in the host defense mechanisms against infectious 
agents by acting as pyrogens, chemotactic factors and by 
exerting regulatory activities on other cells such as 
neutrophils, T cells and B cells is well documented 
(47,98,107,160). However, chronic release or overproduction of 
these cytokines may also be detrimental to the host. 
Macrophages can be activated by several infectious agents with 
potential release of a number of products including hydrolytic 
enzymes and cytokines that participate in the mediation of 
injury through cell recruitment and cytotoxic effects . TNF-
alpha has been shown to be an important mediator of endotoxin-
induced shock in a variety of mammalian species (84,127). It 
has also been demonstrated that IL-1 and TNF can have marked 
pro-inflammatory properties by inducing the synthesis and 
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release of phospholipase A2 , an enzyme which possesses a wide 
range of biological activities (116). 
It has been reported that M· mycoides subsp. mycoides 
(LC) induced TNF, and the injection of TNF in goats induced a 
response similar to that caused by this mycoplasma species 
(127). Increased TNF-alpha concentrations in the lungs of mice 
infected with M· pulmonis has also been demonstrated (51). 
Various other mycoplasmas including M· pneumoniae, and A· 
laidlawii (13) have been shown to have potent activity for 
inducing TNF production from macrophages. In a recent study, 
Almeida et al. (11) reported that encapsulated M· dispar or 
its capsular material did not induce the production of TNF and 
IL-1 from bovine alveolar macrophages, but unencapsulated M· 
dispar did, suggesting that the capsular material could have 
an inhibitory effect on the production of these cytokines . It 
was not mentioned whether the mycoplasma species utilized in 
the previous studies by Rosendal and Faulkner were 
encapsulated or not. The important consideration is that 
either exacerbation or inhibition of release of these products 
from macrophages could have major adverse effects on disease 
processes. 
Mycoplasma-Lymphocyte Interactions Another important 
characteristic of mycoplasmas i s their ability to interact 
nonspecif ically with lymphocytes as first demonstrated by 
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Ginsburg and Nicolet {62) with M· pulmonis. Consequently, this 
interaction may contribute to disease pathogenesis by 
induction of autoimmune antibodies or elaboration of a variety 
of lymphokines that may induce cell injury (31). Several other 
species of mycoplasma have been found to share the potential 
for inducing nonspecific mitogenic activation of lymphocytes. 
M· pneumoniae was found to exert a mitogenic effect on 
lymphocytes from human {19) as well as guinea pig {20) and 
mouse (20,34) lymphocytes. M· arthritidis also was found to be 
mitogenic for rat (32,33) and human (32) lymphocytes . Many 
other species including M· fermentans, M· hominis, A· 
laidlawii, M. arthritidis, M. neurolyticum, M· hyorhinis, M· 
synoviae, M· felis , M· gallisepticum, M· canis, M. 
hyosynoviae, M· arginini, and Spiroplasma citri have been 
reported to have mitogenic activity for mouse lymphocytes and 
sometimes for human and rat lymphocytes (31). This mitogenic 
activity has been demonstrated with whole organisms, extracts 
and membrane preparations (31). 
The mitogenic activity produced by mycoplasmas has also 
been observed in several experiments with either T cells or B 
cells or both from various animal hosts. This indicates the 
possible existence of heterogeneity in the mitogenic activity 
of the various myc oplasma species. M· pneumoniae has been 
reported to activate either B or T lymphocytes or both from 
humans (19), mice (20,34) and guinea p i gs {20). Activation of 
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human and murine T-lymphocytes has been also observed {19). 
Human lymphocytes were activated in vitro by M· pneumoniae, 
Acholeplasma laidlawii, and M· fermentans as well as by M· 
pulmonis {109}. 
Mitogenic activity of mycoplasmas and their products has 
also been shown with in vivo experimentation. This has led to 
the speculation that this may contribute to disease 
pathogenesis. Inoculation of cell membranes or cell membrane 
components into the respiratory tract of experimental animals 
resulted in significant lymphocyte infiltration and 
interstitial pneumonia in some instances {31,106}. 
Also, the interaction of mycoplasmas with lymphocytes can 
result in the induction of a variety of soluble products 
including interferons, interleukins, and chemotactic factors. 
Rinaldo et al. {120} have reported that several mycoplasma 
species were capable of inducing interferon production from 
ovine leukocytes. It has also been reported that human 
lymphocytes produced interferon in response to M· pneumoniae 
{35} and M· synoviae {35,140}. There is evidence that M· 
pulmonis membranes were capable of inducing production of 
significant levels of interleukin-2 from rat lymph node 
lymphocytes {99). The role of these lymphokines, produced by 
activated leukocytes or lymphocytes in the disease process 
depends on their ability to potentiate inflammation by 
recruiting other cells including lymphocytes, macrophages or 
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neutrophils and by stimulating differentiation or activation 
of those cells (31). 
Mycoplasma-Associated Immunosuppression While 
mycoplasma species have been reported to activate lymphocytes, 
suppressive effects on both humeral and cell-mediated 
responses have also been reported by several investigators. 
Kaklamanis and Pavlatos (92) reported that simultaneous 
injections of M· arthritidis and viral antigens resulted in 
complete or partial suppression of humeral responses against 
the antigens. Similarly, M· dispar has also been shown to 
induce immunosuppression when injected in combination with 
other antigens (76). Suppression of humeral and cell-mediated 
responses were reported with M· bovis in calves (17) and M· 
pneumoniae in human (134). 
The effect of certain species of mycoplasma on the 
responsiveness of lymphocytes to mitogenic stimulation have 
been studied. Lymphocytes from cattle experimentally infected 
with M. mycoides subsp. mycoides failed to respond to 
phytohaemagglutinin (PHA) (121). Similarly, inoculation of 
active M· arthritidis extracts into mice resulted in decreased 
responses of lymphocytes to concanavalin A and PHA (2). 
Evidence of mycoplasma species induced-
immunosuppress ion has been shown by their abil i ty to 
potentiate bacterial infections. The potentiating effect of M· 
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pneumoniae on the development of pneumococcal septicemia in 
hamsters by Diplococcus pneumoniae was demonstrated by Lui et 
al. (102). During studies of pyelonephritis in rats, Thomsen 
and Rosendal (150) showed that inoculation of M· arthritidis 
followed by an inoculation of ~. coli provoked severe 
suppurative l esions, while inoculation of high doses of ~. 
coli alone did not produce lesions in rats which had not been 
previously infected with mycoplasmas . 
PAPER: 
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ABSTRACT 
The ability of Mycoplasma ovipneumoniae (field strain) to 
induce alterations in sheep alveolar macrophage functions was 
examined in vitro with live and heat killed organisms. Normal 
alveolar macrophages collected by bronchial lavage of lungs 
were infected with different preparations of M· ovipneumoniae, 
and their capability to ingest Staphylococcus aureus and to 
elicit antibody-dependent cellular cytotoxicity against 
sensitized chicken red blood cells were tested. Controls 
consisted of noninfected macrophages in modified brain heart 
infusion broth or in M199 medium. In addition, the presence of 
surface receptors on these sheep alveolar macrophages and the 
effect of live M· ovipneumoniae on their expression were 
determined by the rosette formation technique. The percentage 
of ~. aureus ingested by nontreated sheep alveolar macrophages 
(controls) was significantly higher than that of infected 
macrophages. Live mycoplasmas were more effective in 
suppressing the ingestion of ~. aureus by these macrophages 
than killed mycoplasmas. Both live and killed mycoplasmas 
suppressed the cytolytic effect of the sheep alveolar 
macrophages to a similar degree. About 78% and 45% of the 
normal sheep alveolar macrophages had IgG and complement 
receptors, respectively . Infection of these macrophages with 
M· ovipneumoniae decreased significantly the expression of IgG 
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receptors but not that of complement receptors. This may 
explain, in part, the impaired ability of these macrophages to 
ingest or lyse a second target. Receptors for IgM were not 
found on any of normal or treated macrophages. Our results 
suggest that these M· ovipneumoniae-induced alterations in 
macrophage functions could contribute to the role that this 
organism may play in sheep respiratory disease. 
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INTRODUCTION 
Ovine pneumonia is considered one of the most common 
infectious diseases of sheep worldwide regardless of 
management systems (1,10,13,18,31,41). The disease is caused 
by a complex interaction of environmental factors producing 
stress and a variety of microorganisms working synergistically 
(10,41). Among these microorganisms, Pasteurella fil2· are 
considered the most commonly isolated from both pneumonic and 
normal sheep. However, challenge experiments have shown that 
Pasteurella fil2· alone have limited abil i ty to produce 
pneumonia and probably require a predisposing infection by 
another infectious agent. A number of microorganisms including 
viruses, mycoplasmas and chlamydia have been suggested to play 
this role (10,16,26,41). 
Among the pulmonary defence mechanisms against infectious 
agents, the phagocytic potential of alveolar macrophages is of 
major importance . Mycoplasmas possess various virulence 
factors that can alter these phagocytic cell functions. Thus, 
this may facilitate colonization of the respiratory tract by 
secondary bacterial agents . Previous in vitro studies have 
shown that in the absence of specific antibodies, several 
mycoplasma species not only can survive quite well in cultures 
of phagocytic cells but can also interfere with ingestion and 
killing of a second bacterial target (5,7,20,21,29,35,39,43). 
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Despite the fact that M· ovipneumoniae is considered the 
most common mycoplasma isolated from ovine lungs (4,6,8,34), 
its role as an important etiologic factor in respiratory 
disease of sheep is still not clearly defined. While extensive 
studies on the experimental infection of sheep with this 
microorganism have been conducted and yielded conflicting 
results (3,11,27,28,40,42), current knowledge of its 
interrelationship with the phagocytic cells of ovine lung is 
extremely limited (2). 
The purpose of the present study was to determine if M· 
ovipneumoniae (isolated from a case of ovine pneumonia) 
suppressed normal sheep alveolar macrophage functions as a 
potential mechanism by which M· ovipneumoniae may contribute 
to respiratory disease in sheep. 
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MATERIALS AND METHODS 
Macrophage Collection 
Alveolar macrophages (AM} were collected by bronchial 
lavage of whole lungs obtained from freshly slaughtered lambs 
and healthy aged sheep that were sacrificed by intravenous 
injection of Beuthanasia-D Special containing 350 mg 
pentobarbitone/ml (Schering-Plough Animal Health Corp., 
Kenilworth, NJ, 10 ml/animal). The trachea was immediately 
exposed and tied below the larynx with a piece of cord to 
avoid any influx of blood. The lungs were then carefully 
removed and two consecutive bronchoalveolar lavages were 
performed by infusing 500 ml of sterile warm phosphate 
buffered saline solution (Dulbecco's PBS, without calcium 
chloride and magnesium chloride, pH 7.4, Sigma Chemical 
Company, St. Louis, MO) containing 10 U heparin/ml (Gibco, 
Grand Island Biological Company, Grand Island, NY), 100 IU 
penicillin/ml (Gibco Laboratories, Grand Island, NY), 100 µg 
Streptomycin sulfate/ml (Gibco Laboratories, Grand Island, 
NY), 50 µg Gentamicin/ml (Sigma Chemical Company St. Louis, 
MO), and 0.125 µg Fungizone/ml (Gibco Laboratories, Grand 
Island, NY) into the lungs through the trachea. The lungs were 
gently massaged and the lavage fluid was poured into a sterile 
Erlenmeyer flask. The lavage fluid was filtered through a 
double layer of cheesecloth into a sterile flask. Cells 
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present in the lavage fluid were washed twice in PBS by 
centrifugation (300 x g for 10 minutes} and the pellets were 
gently resuspended in M199 medium (#380-2340, with Earles'salt 
solution, L-glutamine, sodium bicarbonate and Hepes buffer, 
Gibco BRL, Life Technologies, Inc., Grand Island, NY} 
supplemented with 10% fetal calf serum (FCS, Gibco BRL, Life 
Technologies, Inc., Grand Island, NY} and antibiotics. The 
cell suspensions were depleted of red blood cells, if 
necessary by adding cold, sterile tris-buffered ammonium 
chloride (0.16M NH4Cl and 0.17M tris-HCl, pH 7.65} solution 
for 5 minutes at 37°C, centrifugation, washing and 
resuspension in M199 medium. A sample of the cell suspensions 
was streaked on a glass slide and stained with Diff-Quik stain 
(Baxter Scientific Products, Miami, FL}. A differential count 
was performed. The percentage of viability was determined by 
trypan blue exclusion. Total cell counts were made in a 
hemacytometer chamber (Hausser Scientific, Blue Bell, Pa) and 
the concentration of cells was adjusted as appropriate for 
each experiment. 
Mycoplasma Preparation 
The M· ovipneumoniae isolate used for this study was 
obtained from a pneumonic sheep lung by culture of lung 
tissues. The organism was identified as M· ovipneumoniae by a 
fluorescent antibody (FA) test. Culture impressions were made 
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on glass slides, dried in air and fixed with acetone for 7 
minutes. One to 2 drops of diluted {1:100) primary anti M· 
ovipneumoniae antibody (Ab) (equine origin, prepared by 
immunizing a horse with formalin-killed M· ovipneumoniae) was 
added. After 30 minutes incubation at 37°C, the slides were 
washed twice with PBS, rinsed with distilled water and dried 
in air. After that, two drops of diluted (1:20) secondary 
fluorescein-labeled, rabbit-anti equine globulin (Accurate 
Chemical and Scientific Corp., Westbury, NY) were added. The 
slides were again incubated, washed as previously described, 
and mounted in glycerinated PBS (one part of PBS in 9 parts of 
glycerol) for observation using a fluorescent microscope. 
Colonies of M· ovipneumoniae and M· bovis (courtesy Dr. R. 
Rosenbusch, Veterinary Research Institute, College of Vet. 
Med., Iowa State University, Ames, IA) were included as 
(positive and negative) controls, respectively . 
A stock culture of M· ovipneumoniae was prepared by 
growing the organism in autoclaved modified brain heart 
infusion broth medium (MBHI, pH 7.6: brain heart infusion, 25 
g; neopeptone, 2 . 5 g; bacto-casitone, 2.5 g (Difeo 
Laboratories, Detroit, MI); dextrose (Fisher Scientific, Fair 
Lawn, NJ), 2 g; yeast extract (Difeo Laboratories, Detroit, 
MI), 20 g; distilled water, 800 ml) supplemented with 200 ml 
of horse serum (HyClone Laboratories, Inc. Logan, Utah). Stock 
solutions of bacitracin and thallium acetate (Sigma Chemical 
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Company, st. Louis, MO) were made by adding 2 g of bacitracin 
or 1 g of thallium acetate to 100 ml of distilled water. After 
filtration through a 0.45 µm membrane filter (MSI, Westboro, 
MO), 10 ml of each solution was added to the one liter of 
medium. The number of organisms/ml was determined by the plate 
count method and aliquots were stored at -70°C until used. 
The viability of the stock preparation of M· ovipneumoniae was 
determined at the time of use in each experiment. 
Staphylococcus aureus Inqestion Assay 
The aim of this experiment was to determine if M· 
ovipneumoniae could influence the ingestion of ~. aureus by 
normal sheep alveolar macrophages. Macrophage suspensions 
adjusted to 5 x 106 cells/ml were infected with different 
numbers of M· ovipneumoniae to give a ratio of 1:1, 1:10, 
1:100, 1:1000, or 1:4000 macrophage to mycoplasmas. In 
addition, macrophage suspensions were treated with heat- killed 
M· ovipneumoniae (56°C in water bath for 30 minutes) at a 
ratio of 1:1000 macrophage to mycoplasmas. Controls consisted 
of macrophages in MBHI medium or macrophages in M199 medium. 
Since no major differences between the 2 controls were 
observed during the experiments, only MBHI controls were 
included in the results. After an infection period of 30, 60, 
90, or 120 minutes at 37°C, the macrophages were washed twice 
with PBS by centrifugation (100 x g for 5 minutes) at 37°C, 
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their viability checked by trypan blue exclusion (greater than 
80%), resuspended in M199 medium and assayed for 125I-labeled 
~. aureus ingestion as described previously (38) with some 
modifications. Briefly, 100 µl of 1~I-labeled ~. aureus, 50 µl 
of diluted (1:4) bovine anti-~. aureus serum (courtesy Dr. J. 
Roth, Dept. MIPM, College of Vet. Med., Iowa State University, 
Ames, IA.), and 300 µl of Earle's balanced salt solution 
(EBSS) were added to the tubes and incubated for 10 minutes at 
37°C. Then, 50 µl of a suspension of macrophages treated as 
indicated were added and the tubes were centrifuged (100 x g 
for 5 minutes) and incubated at 37°C for 15 minutes. After 
vortexing, 500 µl of PBS solution containing 0.5 unit of 
lysostaphin was added and incubation allowed to proceed for a 
further 30 minutes. Approximately 2 ml of cold PBS was added 
to stop the reaction, and the tubes were centrifuged at 1250 x 
g for 10 minutes in a refrigerated centrifuge. The supernatant 
was discarded, the cells resuspended in cold PBS and again 
sedimented by centrifugation. The supernatant was discarded 
and the tubes containing the final pellets were placed in a 
gamma counter to determine the counts per minute (CPM) of 
radioactivity present. Each assay included a pair of standard 
tubes which contained ~. aureus but no macrophages or 
lysostaphin. Also, a pair of background tubes which contained 
all reactants except macrophages were included. All samples 
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were set up in duplicate. The percentage of ~. aureus ingested 
was calculated by using the following formula: 
% ingestion= (CPM in test tube)-(CPM in background tube) x 100 
{CPM in standard tube)-{CPM in background tube) 
Cytotoxicity Assay 
The antibody-dependent cell-mediated cytotoxicity (ADCC) 
assay was conducted with 51cr-labeled chicken red blood cells 
{CRBC) as target cells as described previously (30) with minor 
modifications. 
Preparation of 51cr-Labelled Chicken Red Blood Cells 
CRBC were collected in an equal volume of Alsever's 
solution, washed twice in PBS by centrifugation (1500 x g for 
10 minutes), and resuspended in PBS at concentration of 12.5 x 
106 cells/ml. Then, one ml of washed and resuspended CRBC was 
added to 10 ml of PBS and centrifuged as before. The 
supernatant was discarded, the cells resuspended in 0.5 ml of 
M199 medium, and 50 µl (50 µCi) 51cr (Amersham Corporation, 
Arlington Heights, IL) were added and the cells were incubated 
overnight at 37°C in a 5% co2 humidified atmosphere. After this 
incubation period, the cells were washed twice in PBS {1500 x 
g for 10 minutes), and resuspended in 10 ml M199 medium to a 
final concentration of 1.25 x 106 cells/ml. 
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cytotoxicity Procedure 
For the cytotoxicity assay, 100 µl of macrophages 
suspended in M199 medium at a concentration of 3.5 x 106 
cells/ml were placed in each well of a plate (#3596, 96-well, 
Costar Corporation, Cambridge, MA). Then, 50 µl of diluted 
(1:4) bovine anti-CRBC antiserum (courtesy, Dr. J. Roth, Dept . 
MIPM, College of Vet. Med., Iowa State University, Ames, IA) 
and 100 µl of 51cr-labeled CRBC were added to each well . After 
a 7 hour incubation at 37°C in a 5% co2 humidified atmosphere, 
51cr release was measured by harvesting the supernatant onto 
cotton plugs (Skatron cell harvesting equipment, Skatron, 
Norway). The cotton plugs were transferred into tubes, placed 
in a gamma counter and counted for 2 minutes to determine the 
CPM of radioactivity present. 
To determine if ~ ovipneumoniae could interfere with the 
capacity of normal sheep AM to mediate ADCC, macrophage 
suspensions at a concentration of 3.5 x 106 cells/ml were 
incubated with live and heat-killed M· ovipneumoniae diluted 
in M199 mdium (without antibiotics) to give macrophage: 
mycoplasma ratios of 1:10 and 1:100 . After 120 minutes, these 
macrophages were washed twice in PBS by centrifugation (100 x 
g for 5 minutes), their viability checked by trypan blue 
exclusion and assayed for cytotoxic activity. Each assay 
included a pair of standard wells which contained 150 µl of 1% 
Triton x-100 and 100 µl of 51cr-labeled CRBC but no macrophages 
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or anti-CRBC antibodies. Also, a pair of (control) background 
wells which contained all reactants except macrophages were 
included. All samples were set up in duplicate. The percentage 
of 51cr-labeled CRBC lysed was calculated by using the 
following formula: 
% lysis of target cells= (CPM sample)-(CPM background)x 100 
(CPM standard)-(CPM background) 
Assay for surface Receptors 
Preparation of Antibody-coated and complement-coated Sheep Red 
Blood Cells 
Sheep red blood cells (SRBC) were collected in an equal 
volume of Alsever's solution (llOmM glucose, 70mM NaCL, 20mM 
trisodium citrate, 3mM citric acid) and washed 3 times in 
normal saline solution by centrifugation at 500 x g for 20 
minutes. The supernatant was discarded and the packed cells 
were resuspended to a final 1% v/v concentration in PBS+ 
(Dulbecco's PBS with calcium chloride and magnesium chloride, 
pH 7.3, Sigma Chemical Company, St. Louis, MO). Erythrocyte-
antibody complexes were prepared by mixing equal volumes of 1% 
SRBC suspensions with rabbit IgG or Ig~ anti-SRBC serum 
(Cappel, Organon Teknika Corp., West Chester, PA) that were 
diluted in PBS+ at a subagglutinating titer (1:320). The 
mixtures were incubated for 30 minutes at 37°C and for an 
additional 30 minutes at 4°C. These complexes were designated 
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as erythrocyte-IgG (EG) and erythrocyte-IgM (EM), 
respectively. For the preparation of erythrocyte-complement 
{EC) complexes, EM at a 1% concentration were washed once in 
PBS+. Freshly collected sheep serum (known to not agglutinate 
SRBC alone) was added at a rate of 100 µl/ml as a source of 
complement. The mixture was incubated for 30 minutes at 37°C. 
Unsensitized SRBC (E) were prepared by incubating washed SRBC 
in PBS+ in the absence of Ab or C for 30 minutes at 37°C and 
for an additional 30 minutes at 4°C. The various SRBC 
preparations were centrifuged at 300 x g for 5 minutes, and 
cells resuspended to a final concentration of 0 . 5% in M199 
medium. These cells were used immediately in the rosetting 
assays. 
Rosette Formation 
Three ml of a suspension of macrophages {l x 106/ml) were 
dispensed into a polystyrene 25 cm2 tissue culture flask 
{Corning Glass Works, Corning, NY) and incubated at 37°C in a 
5% co2 humidified atmosphere to allow macrophages to adhere. 
After a 4 hour incubation period, the cell monolayers were 
washed gently with warm sterile PBS to remove non-adherent 
cells. The number of adherent macrophages was estimated by 
using 0.2% trypsin (Difeo Labs., Detroit, MI) to release the 
cells in one flask. The number of cells was then counted in a 
hemacytometer. The flasks were reincubated overnight (about 10 
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hours) in M199 medium containing 10% FCS and antibiotics. 
Macrophages in some flasks were infected with live M· 
ovipneumoniae diluted in M199 medium (without antibiotics) to 
give a macrophage:mycoplasma ratio of approximatively 1:10 and 
incubated overnight as well . Observations indicated that the 
viability of macrophages was not affected by the 10-hour 
infection with mycoplasmas. For the rosetting assay, adherent 
macrophages were washed once with PBS, and 2 ml of a SRBC 
preparation (EG, EM, EC, and E) were added to an individual 
flask (in duplicate) . Incubation was allowed to proceed 45 
minutes at 37°C in a 5% co2 humidified atmosphere. At the end 
of this time, the flasks were gently rinsed twice with PBS to 
remove unattached SRBC, and the macrophages were stained with 
Diff-Quik stain. The bottom of each flask was removed, and the 
cells observed through an oil immersion microscope at a 100 X 
magnification. A macrophage with a least 3 SRBC associated 
with its membrane was c onsidered a rosette. A total number of 
200 macrophages were counted randomly for each flask, and the 
percentage of rosette forming cells (RFC} was calculated as: 
% RFC= Number o f RFC x 100 
Total numbe r of counted cells (200) 
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statistical Analysis 
Results were analyzed by analysis of variance (ANOVA). 
Values are reported as mean percentages ± standard error of 
means (SEM). The significance of differences between means was 
accepted when the p value was at least less than 0.05. 
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RESULTS 
Although conditions for identification of the cell 
suspensions were not quite optimal (based only on the 
morphological criteria) the Diff-Quik staining showed 
generally more than 87% of the cells had a morphology 
compatible to that of macrophages, the major contaminating 
cells being lymphocytes. The percentage of viability was 
greater than 95%. 
The effects of live and heat-killed M· ovipneumoniae on 
the ingestion of ~ . aureus by sheep AM are indicated in 
figures 1 and 2. The percentage of~. aureus ingested by non-
treated control AM was significantly higher (p<0.05) than that 
of all preparations of AM pretreated with M· ovipneumoniae 
except for the 1:1 ratio at the 120 minute post-infection 
period. Also, live mycoplasmas were significantly (p<0.05) 
more effective in suppressing the ingestion of ~. aureus by 
sheep AM than killed mycoplasmas (figure 2) . Increasing the 
ratio of M· ovipneumoniae to sheep AM from 1:1 to 4000:1 did 
decrease significantly (p<0.05) the percentage of ~. aureus 
ingested by sheep AM. The suppression was directly related to 
the number of mycoplasma utilized to infect sheep AM. However, 
varying the time intervals of sheep AM infection with M· 
ovipneumoniae from 30 minutes to 120 minutes did not influence 
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significantly the ingestion of ~. aureus by sheep AM 
(Figure 3). 
The effect of M· ovipneumoniae on ADCC activity of sheep 
AM was determined by the ability of normal sheep AM (controls) 
and sheep AM treated with live or heat-killed M· ovipneumoniae 
to lyse 51cr-labeled CRBC (Figure 4). The percentage of 51cr 
released from CRBC by normal sheep AM (42%) was significantly 
higher (p<0.05) than that for sheep AM treated with live or 
heat-killed M· ovipneumoniae (about 12% and 16%, 
respectively). There was no significant difference (p>0.05) 
between live and heat-killed mycoplasmas in depressing sheep 
AM ADCC function. Similarly, increasing the ratio of M· 
ovipneumoniae {live and heat-killed) to sheep AM from 10:1 to 
100:1 did not significantly affect the ability of these AM to 
perform ADCC. 
Both noninfected sheep AM and those infected with live M· 
ovipneumoniae failed to form rosettes with IgM-sensitized or 
with nonopsonized SRBC, while rosettes were observed with IgG-
sensitized and c-sensitized SRBC {Figures 5, 6). About 78% and 
45% of the normal sheep AM formed rosettes with IgG-sensitized 
or c-sensitized SRBC, respectively. The mean percentage of 
infected sheep AM forming rosettes with IgG-sensitized SRBC 
was 58%. This was significantly lower {p<0.05) than that of 
noninfected sheep AM. c-sensitized SRBC termed rosettes with 
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49% of AM infected with M· ov ipneumoniae which was similar to 
the value of noninfected AM. 
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Figure 1. Effects of M· ovipneumoniae treatment of sheep AM on 
~. aureus ingestion. Sheep AM were exposed to live M· 
ovipneumoniae at ratios of 1:1, 1:10, 1:100, 1:1000, or 1:4000 
macrophage to mycoplasmas. Controls consisted of untreated 
sheep AM in MBHI btoth. Values represent mean percentages 
(±SEM) of 5 separate . experiments. Statistical differences from 
control values are indic ated as; a =p<0.05, and b=p >0 . 05 
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~ Untreated (controls) sheep AM 
~ Sheep AM treated with HK mycoplasmas 
Ill Sheep AM treated with live mycoplasmas 
30 60 90 
Time (in minutes) 
120 
Fiqure 2 . Effects of heat-killed (HK), or live M· 
ovipneumoniae on s. aureus ingestion by sheep AM at 
macrophage:mycoplasma ratio of 1:1000. Controls consisted of 
untreated sheep AM in MBHI broth. Values represent mean 
percentages (±SEM) of 5 separate experiments. Statistical 
differences are indicated as a=p<0.05 from control values, and 
b=p<0.05 for live vs HK mycoplasmas. 
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Figure 3. Effects of varying doses of M· ovipneumoniae (A,B,C, 
D,E) and times of infection (30, 60, 90, or 120 minutes) of 
sheep AM on ingestion of ~- aureus. p>0.05 for A vs B,C, and 
p<0.05 for A vs D,E. 
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Figure 4. Effects of live and heat killed (HK) M· 
ovipneumoniae on sheep AM cytotoxic activity at ratios of 
1:10, or 1:100 macrophage to mycoplasmas. Values represent 
mean percentages (±SEM) of 3 separate experiments. Statistical 
differences from control values are indicated as; a=p<0.05 . 
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Figure 5. Sheep AM forming rosettes with IgG-sensitized sheep 
RBC. 
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Fiqure 6. Percentages of sheep AM forming rosettes with 
various SRBC preparations. Sheep AM were either untreated or 
exposed to live M· ovipneumoniae . SRBC preparations were: E= 
nonsensitized, EM= sensitized with IgM, EG= sensitized with 
IgG, and EC= sensitized with complement. Values represent mean 
percentages (±SEM) of 10 separate experiments . The difference 
between a and b was significantly different (p<0.05). 
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DISCUSSION 
The phagocytic effectiveness of phagocytic cells depends 
heavily on their membrane receptors which mediate both 
attachment and ingestion of foreign particles. Evidence is 
presented here to suggest that normal sheep AM express 
receptors for IgG and c but not for IgM. IgG receptors were 
present on about 78% of the normal sheep AM, while only 45% of 
these cells exhibited c receptors . This is quite similar to 
the IgG and C receptor percentages reported in equine (12), 
swine (17), and guinea pig (25) normal AM. However, in man and 
rabbits (36) the percentages of c receptors reported were 93% 
and 80%, respectively which contrast with our findings. The 
absence of AM forming rosettes with IgM-sensitized SRBC found 
i n the present study has been previously reported in swine 
(17) and equine {12) . Few reports have been concerned with 
surface receptors on AM from ruminants . McGuire and Babiuk 
{32) indicated that almost 1 00% of bovine AM that had been 
cultured in vitro for at least 48 hours expressed receptors 
for both IgG and C, but when examined earlier only 29.9% and 
53% of these cells had IgG and C receptors, respectively. 
These authors suggested that the use of unfractionated rabbit 
antisera accounted for the low percentages seen in these early 
cultured cells, but as the cells matured in vitro, the 
expression and the number of cells displaying both Fe and c 
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receptors increased. Fleit et al. (14) used a fluorescence 
assay technique and reported that 62.7% of AM obtained from 5 
day-old lambs had receptors for IgG, but they did not 
investigate the expression of C receptors. Our results 
indicate that 78% of normal AM obtained from adult sheep 
expressed IgG receptors. The technique employed and age-
related differences may account for the difference between 
these two percentages. 
The effect of M. ovipneumoniae on the expression of Fe 
and C receptors on normal sheep AM was investigated in the 
present study. Treatment of sheep AM with live mycoplasmas 
resulted in about a 20% decrease in sheep AM expressing IgG 
receptors, while the percentage of AM exhibiting C receptors 
remained almost constant, as compared with the normal sheep 
AM. The mechanisms involved and why C receptors were not 
affected remain undetermined. However, it is likely that this 
suppression of the IgG receptors by M· ovipneumoniae can 
explain, in part, the impaired ability of these sheep AM to 
ingest ~. aureus or to lyse 51cr-labelled CRBC when pretreated 
with M· ovipneumoniae as demonstrated by the phagocytosis and 
cytotoxicity assays during the present study. 
Exposure of normal sheep AM to M· ovipneumoniae in a low 
number of one AM to 10 mycoplasmas decreased up to one-third 
the bacterial uptake by these phagocytic cells. Decreased 
activity was also observed when sheep AM were exposed to heat-
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killed M· ovipneumoniae but to a more limited degree as 
compared to live mycoplasmas. Also, a steady decline in ~. 
aureus uptake by sheep AM was observed when these macrophages 
were pretreated with increasing concentrations of M· 
ovipneumoniae. This suggests a dose-related response. However, 
varying the time interval of sheep AM infection with M· 
ovipneumoniae did not affect the ingestion of ~. aureus by 
sheep AM. An inhibitory effect in vitro of several mycoplasma 
species on the ability of phagocytic cells to cause 
phagocytosis of a second bacterial target has previously been 
reported (5,20,39,43). Similarly, certain microorganisms other 
than mycoplasmas have also been reported to interact with 
normal phagocytic cells in vitro, resulting in an impaired 
ability to phagocytose a second bacterial target (15,22,37). 
The role of phagocytic cells in the host-defence 
mechanisms depends also on their ability to lyse cells 
infected with various microbes through antibody-dependent 
cellular cytotoxicity (ADCC) or com~lement-dependent 
cytotoxicity. Results of this experimentation indicated that 
normal sheep AM were quite effective in lysing 51cr-labelled 
CRBC (in the presence of specific antibody) as target cells. 
When treated with both live and heat-killed M· ovipneumoniae, 
a significant loss of ability of these sheep AM to lyse the 
target cells was observed. To our knowledge, no such 
experiment with mycoplasma specie s has been reported . However, 
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since mycoplasmas in general are known to induce alterations 
in phagocytic cell functions, it is not surprising that M· 
ovipneumoniae could inhibit sheep AM cytotoxic effect. 
Little is known about the mechanisms that allow 
mycoplasmas to suppress phagocytic cell functions. However, 
evidence exists that the capsular material may exert an anti-
phagocytic effect and also inhibit the ability of phagocytic 
cells to ingest and kill a second bacterial agent. In a recent 
study, Almeida et al. (5) demonstrated that encapsulated M· 
dispar or its purified capsule inhibited the phagocytosis of 
~. aureus or Serratia marcescens by bovine AM. Also, it is 
speculated that the ability of mycoplasmas to inhibit 
phagocytosis is due to their ability to bind firmly to the 
cell membranes of these phagocytes. Thus, this may mask or 
prevent stimulation of appropriate receptors (19) . While it is 
not known whether or not M· ovipneumoniae possesses a capsule, 
electron microscopic studies by Al-Kassi and Alley (2) showed 
that, in the absence of specific antibodies, the organism 
remained attached to the surface of sheep AM without being 
phagocytosed. 
The finding in the present study that M· ovipneumoniae 
decreases the number of IgG receptors on sheep AM may be 
correlated, at least in part, to the impaired ability of these 
macrophages to ingest ~- aureus or to lyse CRBC as target 
cells. Several conditions have been shown to modulate Fe and C 
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receptor expression. Harmsen and Jeska (17) reported a 45% 
increase in C receptor expression in pigs experimentally 
infected with Toxoplasma gondii, while the percentage of AM 
exhibiting IgG receptors remained constant compared to the 
noninfected control pigs. However, they concluded that this 
augmentation of c receptors did not independently enhance the 
ability of these pig AM to endocytose SRBC. These results 
differ from those that we have found. Species variations or 
conditions of experimentation may explain these differences. 
Caruso and Ross (9) reported that the percentage of AM 
phagocytosing opsonized sheep RBC was not affecty by in vivo 
infection of pigs with M· hyopneumoniae alone but, was 
suppressed by a combined infection with IL.. hyopneumoniae and 
A· pleuropneumoniae. 
Other studies have shown that prolonged exposure of 
guinea pigs to corticosteroids in vivo can cause alterations 
in membrane Fe receptor function of AM (24) and the loss of 
these Fe receptors caused a marked decrease in cytotoxic 
effector function of these macrophages (23). Similarly, 
administration of glucocorticoids decreased the number of IgG 
receptors on phagocytic cells from man (33). While our data 
seem consistent with these findings, the manner in which this 
inhibitory effect is exerted remains to be determined. Perhaps 
there is release of certain substances that might alter the 
phagocytic cells' surface membrane or metabolism. However, 
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even with such an hypothesis, why the C receptors were not 
also affected is puzzling. 
In the lung, alveolar macrophages play an important role 
in bacterial clearance mainly by their phagocytic activities. 
Any alteration of this function may compromise the host 
pulmonary defence mechanisms against secondary bacterial 
agents . Results of the present study suggest that M· 
ovipneumoniae can induce alterations in sheep AM functions. 
These in vitro inhibitory effects exerted by M· ovipneumoniae 
on the ability of sheep AM to ingest a second bacterial agent, 
to lyse a target cell , and the diminished expression of IgG 
receptors on these macrophages define a potential role that 
this organism may play in sheep respiratory disease. However, 
the mechanisms involved, and possible components of the 
organism responsible for these inhibitory effects need to be 
investigated further . 
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SUMMARY AND CONCLUSIONS 
The main objective of the present study was to elucidate 
the negative effect that M· ovipneumoniae (isolated from a 
case of ovine pneumonia} exerts on some important functions of 
sheep AM as a potential mechanism by which this organism may 
initiate respiratory disease in sheep. The experimentation 
included the ability of M· ovipneumoniae to suppress the 
capability of sheep AM to ingest ~- aureus, to mediate ADCC, 
and to express membrane surface receptors. 
It was found that exposure of normal sheep AM to M· 
ovipneumoniae in a low number of as many as 10 mycoplasmas per 
macrophage decreased significantly the bacterial uptake and 
the cytotoxic activity of these macrophages . Also, it was 
found that normal sheep AM expressed receptors for IgG and C 
but not for IgM. Treatment of these macrophages with live M. 
ovipneumoniae resulted in about a 20% decrease in the number 
of sheep AM expressing IgG receptors. This suggests that the 
impaired ability of these sheep AM to ingest or to lyse a 
second target is due, in part, to the loss of Fe receptors on 
their surface membrane. However, the role of other mycoplasmal 
components, such as capsular material in preventing the uptake 
of a second bacterial target by phagocytic cells, should be 
investigated , as it has been demonstrated with M· dispar (11} . 
Another possible mechanism is the binding process wi th the 
76 
phagocytic cell membrane that may mask the surface receptors, 
as has been speculated (72). Several species of mycoplasma, 
including M· ovipneumoniae have been shown to attach to the 
surface of phagocytic cells without being phagocytosed, in the 
absence of specific antibody (3,89,115). The possible 
mechanism that allows M· ovipneunmoniae to alter the 
expression of Fe receptors for IgG was not determined in the 
present study. Perhaps the organism is capable of releasing 
certain substances that might alter the surface membrane or 
metabolism of the phagocytic cell. The present in vitro 
findings provide a basis for further investigati ons towards 
understanding the role of M· ovipneumoniae in sheep 
respiratory disease . 
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